Share This

Related Topics News -

     
 Title only   |   Print    Next page > 
     
金斯瑞斥2.25億美元增持CDMO服務附屬Probio Cayman

2025-04-28T  
金斯瑞生物科技甜味蛋白產品獲美國藥監局GRAS認證

2025-04-28T  
金斯瑞上季CARVYKTI貿易銷售淨額3.69億美元 按季升10.5%

2025-04-16T  
《大行》大摩:金斯瑞全球本地化發展助增長 重申「增持」評級

2025-03-17T  
《大行》高盛降金斯瑞目標價至27.34元 去年銷售額達指引下限

2025-03-13T  
《大行》大和:金斯瑞生物科技今年有望轉盈 降目標價至25元

2025-03-13T  
《大行》中銀國際降金斯瑞目標價至21元 維持「買入」評級

2025-03-13T  
《業績》金斯瑞生物科技去年虧轉盈賺29.62億美元 不派息

2025-03-12T  
《大行》摩通:八股份不在AI受益者常規名單中但已經充分利用AI 百勝中國海爾智家中遠海控等有份

2025-02-24T  
《港股》恆指半日跌65點 手機及晶片股逆漲 華虹飆逾17%

2025-02-19T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.